Skip to main content
Erschienen in: Reactions Weekly 1/2023

01.06.2023 | Case report

Vismodegib

Various toxicities: 5 case reports

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Ayen-Rodriguez A, et al. Retrospective Real-Life Data, Efficacy and Safety of Vismodegib Treatment in Patients with Advanced and Multiple Basal Cell Carcinoma: 3-Year Experience from a Spanish Center. International Journal of Environmental Research and Public Health 20: no pagination, No. 10, Jan 2023. Available from: URL: http://doi.org/10.3390/ijerph20105824 Ayen-Rodriguez A, et al. Retrospective Real-Life Data, Efficacy and Safety of Vismodegib Treatment in Patients with Advanced and Multiple Basal Cell Carcinoma: 3-Year Experience from a Spanish Center. International Journal of Environmental Research and Public Health 20: no pagination, No. 10, Jan 2023. Available from: URL: http://​doi.​org/​10.​3390/​ijerph20105824
Metadaten
Titel
Vismodegib
Various toxicities: 5 case reports
Publikationsdatum
01.06.2023
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-42052-y

Weitere Artikel der Ausgabe 1/2023

Reactions Weekly 1/2023 Zur Ausgabe

Case report

Multiple drugs

Case report

Infliximab

Case report

Catequentinib